Warning letter
Xanacare Technologies, LLC: warning letter of Oct 28, 2014
FDA warning letter 439240 · Denver District Office
Key facts
| Reference number | 439240 |
|---|---|
| Company | Xanacare Technologies, LLC |
| Subject | CGMP/QSR/Medical Devices/Adulterated |
| Issue date | Oct 28, 2014 |
| Posted date | Nov 4, 2014 |
| Issuing office | Denver District Office |
| Product type | Devices |
| CFR sections cited | 807.81(b), 807.81(a)(3)(i), 820 |
| Inspection city | Denver |
| Inspection ZIP | 80237 |
| Inspection start date | Jul 31, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: